WebJul 20, 2024 · Jul 20, 2024. For the second time in six years, weight loss-focused company Gelesis Inc. has eschewed the IPO route. But this time, it's still planning to go public — … WebIn April 2024, Gelesis received FDA clearance for its lead product candidate, Plenity®, as an aid for weight management in overweight and obese adults with a Body Mass Index …
Gelesis Named One of the World’s Most Innovative Companies …
WebJun 2, 2024 · CE Mark enables Gelesis to market Plenity™ throughout the European Economic Area. BOSTON, June 2, 2024 - Gelesis, a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to the gastrointestinal (GI) tract, announced today that it has received approval to market … WebWe combine an FDA-cleared weight loss aid with science-backed resources from behavioral science, nutritional research, and psychology to help you take steps toward meaningful change. SEE HOW Healthcare Provider? HCP Site START BY FEELING FULLER Plenity helps you eat less so you can lose weight. senior train travel deals for seniors over 70
Is Gelesis Holdings Inc (GLSH) Stock a Good Investment?
Webwww.gelesis.com Ownership Status Publicly Held Financing Status Formerly VC-backed Primary Industry Drug Discovery Other Industries Biotechnology Stock Exchange NYS Primary Office 501 Boylston Street Suite 6102 Boston, MA 02116 United States +1 (617) 000-0000 Gelesis Timeline 2024 2024 2024 2024 WebJul 19, 2024 · Biotherapeutics company Gelesis will go public on the New York Stock Exchange through a merger with a special acquisition company, elevating the value of the combined businesses to about $1.3bn.. The partnership with Capstar Special Purpose Acquisition is expected to provide $ 376m in gross proceeds Gelesis needs to fund the … Web2 days ago · Gelesis Holdings Inc’s trailing 12-month revenue is $25.8 million with a -368.9% profit margin. Year-over-year quarterly sales growth most recently was -76.8%. … senior townhomes for rent omaha ne